Stay updated on Upadacitinib vs Methotrexate in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in RA Clinical Trial page
- CheckyesterdayChange DetectedA supplemental MedlinePlus resource listing was trimmed, removing a rheumatoid arthritis topic entry and related-link text.SummaryDifference0.1%

- Check8 days agoChange DetectedThe access-denied page has been replaced by the ClinicalTrials.gov record for the completed rheumatoid arthritis study, including its design, outcomes, locations, and supporting documents.SummaryDifference100%

- Check15 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA sitewide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check29 days agoChange DetectedThe revision identifier in the footer of the ClinicalTrials.gov error page changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe ClinicalTrials.gov footer revision label was updated from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

Stay in the know with updates to Upadacitinib vs Methotrexate in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.